New hope against a silent killer: platform trial aims to slash meningitis deaths
NCT ID NCT06666322
First seen Jan 10, 2026 · Last updated May 01, 2026 · Updated 17 times
Summary
This study tests several new antifungal drug combinations for cryptococcal meningitis, a brain infection that is fatal without treatment and still kills many people with HIV. Researchers will enroll 2,000 adults with HIV and this infection to see which combination works best and has fewer side effects. The goal is to find safer, more effective treatments that are easier to access worldwide.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Infectious Diseases Institute
RECRUITINGKampala, Uganda
Contact Email: •••••@•••••
-
Mbarara University of Science and Technology
RECRUITINGMbarara, Uganda
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.